-
1Academic Journal
Authors: V. Likhvantsev, M. Yadgarov, M. Di Piazza, K. Kadantseva, В. В. Лихванцев, М. Я. Ядгаров, К. К. Каданцева
Source: General Reanimatology; Том 16, № 6 (2020); 91-104 ; Общая реаниматология; Том 16, № 6 (2020); 91-104 ; 2411-7110 ; 1813-9779 ; 10.15360/1813-9779-2020-6
Subject Terms: анестетическое прекондиционирование, volatile anesthesia vs TIVA, anesthesia for cancer patients, anesthetic preconditioning, периоперационая смертность, ингаляционная анестезия, внутривенная анестезия, анестезия онкологических пациентов
File Description: application/pdf
Relation: https://www.reanimatology.com/rmt/article/view/1988/1468; https://www.reanimatology.com/rmt/article/view/1988/1469; Лихванцев В.В., Мороз В.В., Гребенчиков О.А., Гороховатский Ю.И., Заржецкий Ю.В., Тимошин С.С., Левиков Д.И., Шайбакова В.Л. Ишемическое и фармакологическое прекондиционирование. Общая реаниматология. 2011; 7 (6): 5-9. DOI:10.15360/18139779-2011-6-59; Murry C.E., Jennings R.B., Reimer K.A. Precondicioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986; 74 (5): 1124-1136. DOI:10.1161/01.cir.74.5.1124.; Reimer K.A., Murry C.E., Yamasawa I., Hill M.L., Jennings R.B. Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis. Am J Physiol 1986; 251 (6 Pt 2): H1306-15. DOI:10.1152/ajpheart.1986.251.6.H1306.; Reimer K.A., Jennings R.B. The «wavefront phenomenon» of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest. 1979; 40 (6): 633-644. PMID: 449273; Cason B.A., Gamperl A.K., Slocum R.E., Hickey R.F. Anesthetic-induced preconditioning: previous administration of isoflurane decreases myocardial infarct size in rabbits. Anesthesiology. 1997; 87 (5): 1182-1190. DOI:10.1097/00000542-199711000-00023.; Cope D.K., Impastato W.K., Cohen M.V., Downey J.M. Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology.1997; 86 (3): 699-709. DOI:10.1097/00000542199703000-00023.; Kersten J.R., Schmeling T.J., Pagel P.S., Gross G.J., Warltieret D.C. Isoflu-rane mimics ischemic preconditioning via activation of K (ATP) channels: reduction of myocardial infarct size with an acute memory phase. Anesthesiology.1997; 87 (2): 361-370. DOI:10.1097/00000542199708000-00024.; Kunst G., Klein A.A. Peri-operative anesthetic myocardial preconditioning and protection — cellular mechanisms and clinical relevance in cardiac anaesthesia. Anesthesia. 2015; 70 (4): 467-482. DOI:10.1111/anae.12975.; Sivaraman V., Pickard J.M., Hausenloy D.J. Remote ischaemic conditioning: cardiac protection from afar. Anaesthesia. 2015; 70 (6): 732748. DOI:10.1111/anae.12973.; Maldonado Y., Weiner M.M., Ramakrishna H. Remote Ischemic Preconditioning in Cardiac Surgery: Is There a Proven Clinical Benefit? J Cardiothorac Vasc Anesth. 2017; 31 (5): 1910-1915. DOI:10.1053/j.jvca.2017.03.043.; Зарубина И.В., Гориянов А.В., Шабанов П.Д. Молекулярные механизмы ишемического и фармакологического прекондиционирования. Обзоры по клинической фармакологии и лекарственной терапии. 2010; VIII (2): 3-12.; De Hert S.G., van der Linden P.J., ten Broecke P.W., Vermeylen K.T., Ro-drigus I.E., Stockman B.A. Effects of desfluran and sevoflurane on lengthdependent regulation of myocardial function in coronary surgery patients. Anesthesiology. 2001; 95 (2): 357-363. PMID: 11506106 DOI:10.1097/00000542-200108000-00016; De Hert S.G., Cromheecke S., ten Broecke P.W., Mertens E., De Blier I.G., Stockman B.A., Rodrigus I.E. Van der Linden P.J. Effects of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesthesiology. 2003; 99 (2): 314-323. DOI:10.1097/00000542200308000-00013.; De Hert S.G., ten Broecke P.W., Mertens E., Van Sommeren E.W., De Blier I.G., Stockman B.A., Rodrigus I.E. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology. 2002; 97 (1): 42-49. DOI:10.1097/00000542-200207000-00007.; De Hert S.G., Longrois D., Yang H., Fleisher L.A. Does the use of a volatile anesthetic regimen attenuate the incidence of cardiac events after vascular surgery? Acta Anaesthesiol Belg. 2008; 59 (1): 19-25.; Landoni G., Biondi-Zoccai G.G., Zangrillo A., Bignami E., D’Avolio S., Marchetti C., Calabro M.G., Fochi O., Guarracino F, Tritapepe L., De Hert S., Torri G. Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth. 2007; 21 (4): 502-511. DOI:10.1053/j.jvca.2007.02.013.; Uhlig C, Bluth T, Schwarz K, Deckert S., Heinrich L., De Hert S., Lan-doni G., Serpa Neto A., Schultz M.J., Pelosi P., Schmitt J., Gama de Abreu M. Effects of volatile anesthetics on mortality and postoperative pulmonary and other complications in patients undergoing surgery: a systematic review and meta-analysis. Anesthesiology. 2016; 124 (6): 1230-1245. DOI:10.1097/ALN.0000000000001120.; Landoni G., Greco T., Biondi-Zoccai G., Nigro Neto C., Febres D., Pin-taudi M., Pasin L,. Cabrini L., Finco G., Zangrillo A. Anaesthetic drugs and survival: a Bayesian network meta-analysis of randomized trials in cardiac surgery. Br J Anaesth. 2013; 111 (6): 886-896. DOI:10.1093/bja/aet231.; Garcia C., Julier K., Bestmann L., Zollinger A., von Segesser L.K., Pasch T., Spahn D.R., Zaugg M. Preconditioning with sevoflurane decreases PECAM-1 expression and improves oneyear cardiovascular outcome in coronary artery bypass graft surgery. Br J Anaesth. 2005; 94 (2): 159165. DOI:10.1093/bja/aei02.; De Hert S, Vlasselaers D, Barb. R, Ory J.P., Dekegel D., Donnadonni R., Demeere J.L., Mulier J., Wouters P. A. comparison of volatile and nonvolatile agents for cardioprotection during onpump coronary surgery. Anesthesia. 2009; 64 (9): 953-960. DOI:10.1111/j.1365-2044.2009.06008.x.; Likhvantsev V.V., Landoni G., Levikov D.I., Grebenchikov O.A., Skripkin Y.V., Cherpakov R.A. Sevoflurane versus total intravenous anesthesia for isolated coronary artery bypass surgery with cardiopulmonary bypass: a randomized trial. J Cardiothorac Vasc Anesth. 2016; 30 (5): 1221-1227. DOI:10.1053/j.jvca.2016.02.030.; Kunst G., Klein A.A. Peri-operative anaesthetic myocardial preconditioning and protection — cellular mechanisms and clinical relevance in cardiac anaesthesia. Anesthesia. 2015; 70 (4): 467-482. DOI:10.1111/anae.12975; Symons J.A., Myles P.S. Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis. Br J Anaesth. 2006; 97 (2): 127-136. DOI:10.1093/bja/ael149.; Yu C.H., Beattie W.S. The effects of volatile anesthetics on cardiac ischemic complications and mortality in CABG: a meta-analysis. Can J Anaesth. 2006 Sep; 53 (9): 906-118. DOI:10.1007/BF03022834.; Landoni G., Rodseth R.N., Santini F, Ponschab M., Ruggeri L., Szekely A., Pasero D, Augoustides J.G., Del Sarto P.A., Krzych L.J., Corcione A., Slullitel A., Cabrini L., Le Manach Y., Almeida R.M., Bignami E., Biondi-Zoccai G., Bove T., Caramelli F., Cariello C., Carpanese A., Clar-izia L., Comis M., Conte M., Covello R.D., De Santis V., Feltracco P., Giordano G., Pittarello D., Gottin L., Guarracino F., Morelli A., Musu M., Pala G., Pasin L., Pezzoli I., Paternoster G., Remedi R., Roasio A., Zuc-chetti M., Petrini F., Finco G., Ranieri M., Zangrillo A. Randomized evidence for reduction of perioperative mortality. J Cardiothorac Vasc Anesth. 2012; 26 (5): 764-772. DOI:10.1053/j.jvca.2012.04.018.; Landoni G., Pisano A., Lomivorotov V., Alvaro G., Hajjar L., Paternoster G., Nigro Neto C., Latronico N., Fominskiy E., Pasin L., Finco G., Lo-breglio R., Azzolini M.L., Buscaglia G., Castella A., Comis M., Conte A., Conte M., Corradi F., Dal Checco E., De Vuono G., Ganzaroli M., Garofalo E., Gazivoda G., Lembo R., Marianello D., Baiardo Redaelli M., Monaco F., Tarzia V., Mucchetti M., Belletti A., Mura P., Musu M., Pala G., Paltenghi M., Pasyuga V., Piras D., Riefolo C., Roasio A., Ruggeri L., Santini F., Szekely A., Verniero L., Vezzani A., Zangrillo A, Bellomo R. Randomized evidence for reduction of perioperative mortality: an updated consensus process. J Cardiothorac Vasc Anesth. 2017; 31 (2): 719-730. DOI:10.1053/j.jvca.2016.07.017.; Hillis L.D., Smith P.K., Anderson J.L. Bittl J.A., Bridges C.R., Byrne J.G., Cigarroa J.E., Disesa VJ., Hiratzka L.F., Hutter A.M. Jr., Jessen M.E., Keeley E.C., Lahey S.J., Lange R.A., London M.J., Mack M.J., Patel M.R., Puskas J.D., SabikJ.F, Seines O., ShahianD.M., Trost J.C., WinnifordM.D. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011; 124 (23): 2610-2642. DOI:10.1161/CIR.0b013e31823b5fee.; Sousa-Uva M, Head SJ, Milojevic M, Collet J.P., Landoni G., Castella M., Dunning J., Gudbjartsson T., Linker N.J., Sandoval E., Thielmann M., Jeppsson A., Landmesser U. 2017 EACTS guidelines on perioperative medication in adult cardiac surgery. Eur J Cardiothorac Surg. 2018; 53 (1): 5-33. DOI:10.1093/ejcts/ezx314.; Lurati Buse G.A., Schumacher P., Seeberger E., Studer W., Schuman R.M., Fassl J., Kasper J., Filipovic M., Bolliger D., Seeberger M.D. Randomized Comparison of Sevoflurane Versus Propofol to Reduce Perioperative Myocardial Ischemia in Patients Undergoing Noncardiac Surgery. Circulation. 2012; 126 (23): 2696-2704. DOI:10.1161/CIR-CULATIONAHA.112.126144; Kristensen S.D., Knuuti J., Saraste A., Anker S., B0tker H.E., Hert S.D., Ford I., Gonzalez-Juanatey J.R., Gorenek B., Heyndrickx G.R., Hoeft A., Huber K., lung B., Kjeldsen K.P, Longrois D., Lbscher TF, Pierard L., Pocock S., Price S., Roffi M., Sirnes P.A., Sousa-Uva M., Voudris V., Funck-Brentano C. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). European Heart Journal. 2014; 35 (35): 2383-2431. DOI:10.1093/eurheartj/ehu282.; Liberati A., Altman D.G., Tetzlaff J., Mulrow C., G0tzsche PC., loannidis J.P., Clarke M., Devereaux P.J., Kleijnen J., Moher D. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration. PLoS Med. 2009; 6 (7): e1000100. DOI:10.1371/journal.pmed.1000100.; Moher D., Liberati A., Tetzlaff J., Altman D.G., The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009; 6 (7): e1000097. DOI:10.1371/journal.pmed.1000097.; Young C., Horton R. Putting clinical trials into context. Lancet. 2005; 366 (9480): 107-108. DOI:10.1016/S0140-6736(05)66846-8.; Dixon E., Hameed M., Sutherland F., Cook D.J., Doig C. Evaluating metaanalyses in the general surgical literature: a critical appraisal. Ann Surg. 2005; 241 (3): 450-459. DOI:10.1097/01.sla.0000154258.30305.df.; Jiao X.F., Lin X.M., Ni X.F., Li H.L., Zhang C., Yang C.S., Song H.X., Yi Q.S., Zhang L.L.Volatile Anesthetics Versus Total Intravenous Anesthesia in Patients Undergoing Coronary Artery Bypass Grafting: An Updated Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials. PLoS One. 2019; 14 (10): e0224562. DOI:10.1371/journal.pone.0224562.; Ren S.F., Yu H., Guo Y.Q., Yu H. Inhalation Versus Intravenous Anesthesia for Adults Undergoing Heart Valve Surgery: A Systematic Review and Meta-Analysis. Minerva Anestesiol. 2019; 85 (6): 665-675. DOI:10.23736/S0375-9393.19.13377-9.; Landoni G., Lomivorotov V.V., Nigro Neto C., Monaco F., Pasyuga V.V., Bradic N., Lembo R., Gazivoda G., Likhvantsev V.V., Lei C., Lozovskiy A., Di Tomasso N., Bukamal N.A.R., Silva F.S., Bautin A.E., Ma J., Criv-ellariM., FaragA.M.G.A., UvalievN.S., Carollo C., PieriM., Kunstyf J., WangC.Y., BellettiA., HajjarL.A., GrigoryevE.V,AgroF.E.,RihaH., El-Tahan M.R., Scandroglio A.M., Elnakera A.M., Baiocchi M., Navalesi P., Shmyrev V.A., Severi L., Hegazy M.A., Crescenzi G., Ponomarev D.N., Brazzi L., Arnoni R., Tarasov D.G., Jovic M., Calabro M.G., Bove T., Bel-lomo R., Zangrillo A.; MYRIAD Study Group. Volatile Anesthetics versus Total Intravenous Anesthesia for Cardiac Surgery. N Engl J Med. 2019; 380 (13): 1214-1225. DOI:10.1056/NEJMoa1816476.; Wigmore T.J, Mohammed K., Jhanji S. Long-term Survival for Patients Undergoing Volatile Versus IV Anesthesia for Cancer Surgery: A Retrospective Analysis. Anesthesiology. 2016; 124 (1): 69-79. DOI:10.1097/ALN.0000000000000936.; Enlund M., Berglund A., Andreasson K., Qiqek C., Enlund A., Bergkvist L. The choice of anaesthetic—sevoflurane or propofol—and outcome from cancer surgery: a retrospective analysis. Upsala journal of medical sciences. 2014; 119 (3): 251-261. DOI:10.3109/03009734.2014.922649.; Oh TK.,KimH.H., JeonY.TRetrospective analysis of 1-year mortality after gastric cancer surgery: Total intravenous anesthesia versus volatile anesthesia. Acta Anaesthesiologica Scandinavica. 2019; 63 (9): 1169-1177. DOI:10.1111/aas.13414.; Kim M.H., Kim D.W., Kim J.H., Lee K.Y., Park S., Yoo Y.C. Does the type of anesthesia really affect the recurrence-free survival after breast cancer surgery? Oncotarget. 2017; 8 (52): 90477-90487. DOI:10.18632/oncotarget.21014.; Jun I.J., Jo J.Y., Kim J.I., Chin J.H., Kim W.J., Kim H.R., Lee E.H., Choi I.C. Impact of anesthetic agents on overall and recurrence-free survival in patients undergoing esophageal cancer surgery: a retrospective observational study. Scientific reports. 2017; 7 (1): 14020. DOI:10.1038/s41598-017-14147-9.; Oh T.K., Kim K., Jheon S., Lee J., Do S.H., Hwang J.W., Song I.A. Longterm oncologic outcomes for patients undergoing volatile versus intravenous anesthesia for non-small cell lung cancer surgery: a retrospective propensity matching analysis. Cancer Control. 2018; 25 (1): 1073274818775360. DOI:10.1177/1073274818775360.; Wu Z.F., Lee M.S., Wong C.S., Lu C.H., Huang Y.S., Lin K.T., Lou Y.S., Lin C., Chang Y.C., Lai H.C. Propofol-based total intravenous anesthesia is associated with better survival than desflurane anesthesia in colon cancer surgery. Anesthesiology. 2018; 129 (5): 932-941. DOI:10.1097/ALN.0000000000002357.; Zheng X., Wang Y., Dong L., Zhao S., Wang L., Chen H., Xu Y., Wang G. Effects of propofol-based total intravenous anesthesia on gastric cancer: a retrospective study. OncoTargets and therapy. 2018; 11: 11411148. DOI:10.2147/OTT.S156792.; Yoo S., Lee H.B., Han W., Noh D.Y., Park S.K., Kim W.H., Kim J.T. Total Intravenous Anesthesia versus Inhalation Anesthesia for Breast Cancer SurgeryA Retrospective Cohort Study. Anesthesiology. 2019; 130 (1): 31-40. DOI:10.1097/ALN.0000000000002491.; Dong J., Zeng M., Ji N., Hao S., Zhou Y., Gao Z., Gu H., Zhang L., Ma D., Peng Y., Han R. Impact of anesthesia on long-term outcomes in patients with supratentorial high-grade glioma undergoing tumor resection: a retrospective cohort study. Journal of Neurosurgical Anesthesiology. 2020; 32 (3): 227-233. DOI:10.1097/ANA.0000000000000588.; De Hert S.G., Turani F., Mathur S., Stowe D.F. Cardioprotection with volatile anesthetics: mechanisms and clinical implications. Anesth. Analg. 2005; 100 (6): 1584-1593. DOI:10.1213/01.ANE.0000153483.61170.0C.; Stowe D.F, Kevin L.G. Cardiac preconditioning by volatile anesthetic agents: a defining role for altered mitochondrial bioenergetics. Antioxid Redox Signal. 2004; 6 (2): 439-448. DOI:10.1089/152308604322899512.; Riess M.L, Novalija E., Camara A.K., Eells J.T, Chen Q., Stowe D.F. Preconditioning with sevoflurane reduces changes in nicotinamide adenine dinucleotide during ischemia-reperfusion in isolated hearts: reversal by 5-hydroxydecanoic acid. Anesthesiology. 2003; 98 (2): 387-395. DOI:10.1097/00000542-200302000-00019.; Борисов К.Ю., Мороз В.В., Гребенчиков О.А., Плотников Е.Ю., Левиков Д.И., Черпаков Р.А., Лихванцев В.В. Влияние пропофола на анестетическое прекондиционирование миокарда севофлураном. Общая реаниматология. 2013; IX (4): 30-35. DOI:10.15360/1813-9779-2013-4-30; Мороз В.В., Борисов К.Ю., Гребенчиков О.А., Левиков Д.И., Шайбакова В.Л., Черпаков Р.А., Лихванцев В.В. Анестетическое прекондиционирование миокарда и некоторые биохимические маркеры сердечной и коронарной недостаточности после операций аортокоронарного шунтирования. Общая реаниматология. 2013; IX (5): 29-35.; Лихванцев В.В., Тимошин С.С., Гребенчиков О.А. Борисов К.Ю., Шайбакова В.Л., Габитов М.В. Анестетическое прекондиционирование миокарда в некардиальной хирургии. Вестник анестезиологии и реаниматологии. 2011; VIII (6): 4-9.; Лихванцев В.В., Тимошин С.С., Гребенчиков О.А., Шапошников А.А., Скрипкин Ю.В., Борисов К.Ю. Клиническая значимость анестетического прекондиционирования у пациентов высокого риска в некардиальной хирургии. Вестник анестезиологии и реаниматологии. 2012; IX (3): 003-007.; Тимошин С.С., Шапошников А.А., Гребенчиков О.А., Борисов К.Ю., Черпаков Р.А., Лихванцев В.В. Сравнительная характеристика опиоидного и анестетического прекондиционирования у больных группы «Высокого риска развития кардиальных осложнений» в общей хирургии. Медицинский алфавит. 2012; III (18): 50-53.; Juhaszova M., Rabuel C., Zorov D.B., Lakatta E.G., Sollott S.J. Protection in the aged heart: preventing the heart-break of old age? Cardiovascular Research. 2005; 66: 233-244. DOI:10.1016/j.cardiores.2004.12.020; Powers S.K., Quindry J., Hamilton K. Aging, exercise, and cardioprotection. Ann N Y Acad Sci. 2004; 1019: 462-470. DOI:10.1196/an-nals.1297.084.; Juhaszova M., Zorov D.B., Kim S.H., Pepe S., Fu Q., Fishbein K.W., Ziman B.D, Wang S., Ytrehus K., Antos C.L., Olson E.N., Sollott S.J. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest. 2004; 113 (11): 1535-1549. DOI:10.1172/JCI19906.; Rosenfeldt F.L., Pepe S., Linnane A., Nagley P., Rowland M., Ou R., Marasco S., Lyon W. The effects of ageing on the response to cardiac surgery: protective strategies for the ageing myocardium. Biogerontology. 2002; 3 (1-2): 37-40. DOI:10.1023/a:1015299127969.; Tanaka K., Ludwig L.M., Krolikowski J.G., Alcindor D., Pratt P.F., Kersten J.R., Pagel P.S., Warltier D.C. Isoflurane produces delayed pre-condicioning against myocardial ischemia a reperfusion injury: role of cyclooxygenase-2. Anesthesiology. 2004; 100 (3): 525-531. DOI:10.1097/00000542-200403000-00010.; Alcindor D., Krolikowski J.G., Pagel P.S., Warltier D.C., Kersten J.R. Cyclooxygenase-2 mediates ischemic, anesthetic, and pharmacologic preconditioning in vivo. Anesthesiology. 2004; 100 (3): 547-554. DOI:10.1097/00000542-200403000-00013.; Bolli R., Shinmura K., Tang X.L., Kodani E., Xuan Y.T., Guo Y., Dawn B. Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning. Cardiovasc Res. 2002; 55 (3): 506-519. DOI:10.1016/s0008-6363(02)00414-5.; Nigro Neto C., Landoni G., Cassara L., De Simone F., Zangrillo A., Tardelli M.A. Use of volatile anesthetics during cardiopulmonary bypass: a systematic review of adverse events. J Cardiothorac Vasc Anesth. 2014; 28 (1): 84-89. DOI:10.1053/j.jvca.2013.05.030.; Wiesenack C., Wiesner G., Keyl C., Gruber M., Philipp A., Ritzka M., Prasser C., Taeger K. In vivo uptake and elimination of isoflurane by different membrane oxygenators during cardiopulmonary bypass. Anesthesiology. 2002; 97 (1): 133-138. DOI:10.1097/00000542200207000-00019.; Cromheecke S., Pepermans V., Hendrickx E., Lorsomradee S., Ten Broecke P.W., Stockman B.A., Rodrigus I.E., De Hert S.G. Cardioprotective properties of sevoflurane in patients undergoing aortic valve replacement with cardiopulmonary bypass. Anesth Analg. 2006; 103 (2): 289-296. DOI:10.1213/01.ane.0000226097.22384.f4.; De Hert S., Vlasselaers D., Barbe R., Ory J.P., Dekegel D., Donnadonni R., Demeere J.L., Mulier J., Wouters P. A comparison of volatile and non volatile agents for cardioprotection during on-pump coronary surgery. Anaesthesia. 2009; 64 (9): 953-960. DOI:10.1111/j.1365-2044.2009.06008.x.; Задорожный М.В., Яворовский А.Г., Зюляева Т.П., Исаева А.М., Винницкий Л.И., Бунятян А.А. Методика фармакологического прекондиционирования миокарда галогенсодержащими анестетиками у кардиохирургических пациентов. Анестезиология и реаниматология. 2008; 5: 4-8.; Kurosawa S., Kato M. Anesthetics, immune cells, and immune responses. J Anesth. 2008; 22 (3): 263-277. DOI:10.1007/s00540-008-0626-2.; Vallejo R., Hord E.D., Barna S.A., Santiago-Palma J., Ahmed S. Perioperative immunosuppression in cancer patients. J Environ Pathol Toxicol Oncol. 2003; 22 (2): 139-146. DOI:10.1615/jenvpathtoxoncol.v22.i2.70.; Wang L., Zha B., Shen Q., Zou H., Cheng C., Wu H., Liu R. Sevoflurane Inhibits the Th2 Response and NLRP3 Expression in Murine Allergic Airway. Inflammation. 2018; 2018: 9021037. DOI:10.1155/2018/9021037.; Schutte D, Zwitserloot AM, Houmes R, de Hoog M, Draaisma JM, Lemson J. Sevoflurane therapy for life-threatening asthma in children. J Anaesth. 2013; 111 (6): 967-970. DOI:10.1093/bja/aet257.; Bauer M., Rensing H., Ziegenfuss T. Anesthesia and perioperative immune function. Anaesthesist. 1998; 47 (7): 538-556. DOI:10.1007/s001010050595.; Snyder G.L., Greenberg S. Effect of anesthetic technique and other perioperative factors on cancer recurrence. Br J Anaesth. 2010; 105 (2): 106-115. DOI:10.1093/bja/aeq164.; Stollings L.M., Jia L.J., Tang P., Dou H., Lu B., Xu Y. Immune Modulation by Volatile Anesthetics. Anesthesiology. 2016; 125 (2): 399-411. DOI:10.1097/ALN.0000000000001195.; Sedghi S., Kutscher H.L., Davidson B.A., Knight P.R. Volatile Anesthetics and Immunity. Immunol Invest. 2017; 46 (8): 793-804. DOI:10.1080/08820139.2017.1373905.; Fahlenkamp A.V., Coburn M., Rossaint R., Stoppe C., Haase H. Comparison of the effects of xenon and sevoflurane anaesthesia on leucocyte function in surgical patients: a randomized trial. Br JAnaesth. 2014; 112 (2): 272-280. DOI:10.1093/bja/aet330. Epub 2013 Oct 16.; Cho J.S., Lee M.H., Kim S.I., Park S., Park H.S., Oh E., Lee J.H., Koo B.N. The Effects of Perioperative Anesthesia and Analgesia on Immune Function in Patients Undergoing Breast Cancer Resection: A Prospective Randomized Study. Int J Med Sci. 2017; 14 (10): 970-976. DOI:10.7150/ijms.20064.eCollection2017.; Jin Y., Zhao X., Li H., Wang Z., Wang D. Effects of sevoflurane and propofol on the inflammatory response and pulmonary function of perioperative patients with one-lung ventilation. Exp Ther Med. 2013 Sep; 6 (3): 781-785. DOI:10.3892/etm.2013.1194.; De Hert S, Moerman A. Anesthetic Preconditioning: Have We Found the Holy Grail of Perioperative Cardioprotection? J Cardiothorac Vasc Anesth. 2018; 32 (3): 1135-1136. DOI:10.1053/j.jvca.2018.01.001.; Pagel P.S., Crystal G.J. The Discovery of Myocardial Preconditioning Using Volatile Anesthetics: A History and Contemporary Clinical Perspective. J Cardiothorac Vasc Anesth. 2018; 32 (3): 1112-1134. DOI:10.1053/j.jvca.2017.12.029.; https://www.reanimatology.com/rmt/article/view/1988
-
2Academic Journal
Authors: V. V. Likhvantsev, В. В. Лихванцев
Source: Messenger of ANESTHESIOLOGY AND RESUSCITATION; Том 16, № 2 (2019); 25-33 ; Вестник анестезиологии и реаниматологии; Том 16, № 2 (2019); 25-33 ; 2541-8653 ; 2078-5658
Subject Terms: анестетическое прекондиционирование, peri-operative period, dextrans. albumin, cardiac failure, levosimendan, anesthetic preconditioning, периоперационный период, декстраны, альбумин, сердечная недостаточность, левосимендан
File Description: application/pdf
Relation: https://www.vair-journal.com/jour/article/view/316/338; Лихванцев В. В. Ингаляционная индукция и поддержание анестезии. ‒ М.: МИА, 2013. ‒ 320 с.; Лихванцев В. В. Инфузионная терапия в периоперационном периоде // Вестник анестезиологии и реаниматологии. – 2016. – Т. 13, № 5. – С. 66‒74.; Лихванцев В. В., Гребенчиков О. А., Борисов К. Ю. и др. Общие анестетики: определение и механизм действия // Медицинский алфавит: неотложная медицина – 2013. ‒ № 3. ‒ С. 18‒24.; Лихванцев В. В., Гребенчиков О. А., Шмелёва Е. А. и др. Анестетическое прекондиционирование: почему данные, полученные в эксперименте, не всегда подтверждаются в клинике? // Вестник анестезиологии и реаниматологии. ‒ 2013. ‒ Т. 10, № 4. ‒ С. 9‒14.; Лихванцев В. В., Мороз В. В., Гребенчиков О. А. и др. Ишемическое и фармакологическое прекондиционирование // Общая реаниматология. ‒ 2012. ‒ Т. VIII, № 1. ‒ С. 61‒66.; Лихванцев В. В., Ломиворотов В. В., Марченко Д. Н. и др. Предоперационная профилактика сердечной недостаточности в некардиальной хирургии // Общая реаниматология. ‒ 2016. ‒ Т. 11, № 3 ‒ С. 61‒69. DOI: http://dx.doi.org/10.15360/1813-9779-2016-3.; Лихванцев В. В. Анестезия, анальгезия, ноцицепция ‒ как совместить теорию и практику? Комментарий к статье А. Е. Карелова, К. М. Лебединского, В. И. Буравцова «Анестетик, анальгетик, гипнотик ‒ важны ли термины?» // Вестник анестезиологии и реаниматологии. – 2015. ‒ Т. 12, № 5. ‒ С. 11‒15.; Шевченко Ю. Л., Гороховатский Ю. И., Азизова О. А. и др. Севофлуран в кардиохирургии // Кардиология и сердечно-сосудистая хирургия. ‒ 2009. ‒ Т. 2, № 2. ‒ С. 58‒65.; Afshari A., De Hert S. Pitfalls of clinical practice guidelines in the era of broken science // Eur. J. Anaesthesiol. – 2018. – Vol. 35. – P. 903–906.; Brunkhorst F. M., Engel C., Bloos F. et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis // N. Engl. J. Med. ‒ 2008. – Vol. 358. – P. 125–139.; Cason B. A., Gamperl A. K., Slocum R. E. et al. Anesthetic-induced precondicioning: previous administration of isoflurane decreases myocardial infarct size in rabbits // Anesthesiology. ‒ 1997. ‒ Vol. 87. ‒ P. 1182‒1190.; Cholley B., Caruba T., Grosjean S. et al. Effect of levosimendan on low cardiac output syndrome in patients with low ejection fraction undergoing coronary artery bypass grafting with cardiopulmonary bypass: The LICORN Randomized Clinical Trial // JAMA. – 2017. – Vol. 318. – P. 548‒556.; de Backer D., Donadello K., Taccone F. S. et al. Microcirculatory alterations: potential mechanisms and implications for therapy // Ann. Intens. Care. – 2011. – Vol. 1. ‒ Р. 27.; de Hert S. Cardioprotection by volatile anesthetics: What about noncardiac surgery? // J. Cardiothorac. Vasc. Anesth. – 2011. – Vol. 25. – P. 899–901.; de Hert S., Moerman A. Anesthetic preconditioning: have we found the holy grail of perioperative cardioprotection? // J. Cardioth. Vascular Anesthesia. – 2018. – Vol. 32, № 3. – P. 1135–1136.; de Hert S. G., Turani F., Mathur S. et al. Cardioprotection with volatile anesthetics: mechanisms and clinical implications // Anesth. Analg. ‒ 2005. ‒ Vol. 100. ‒ P.1584–1593.; du Toit E. F., Genis A., Opie L. H. et al. A role for the RISK pathway and KATP channels in pre- and post-conditioning induced by levosimendan in the isolated guinea-pig heart // Br. J. Pharmacol. – 2014. – Vol. 154. – P. 41–50.; Eriksson O., Pollesello P., Haikala H. Effect of levosimendan on balance between ATP production and consumption in isolated perfused guinea-pig heart before ischemia or after reperfusion // J. Cardiovasc. Pharmacol. – 2004. – Vol. 44. – P. 316–321.; Ferdinandy P., Schulz R., Baxter G.T. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning // Pharmacol. Rev. ‒ 2007. ‒ Vol. 59. ‒ P. 418–458.; Finfer S., Bellomo R., Boyce N. et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit // N. Engl. J. Med. – 2004. – Vol. 350. – P. 2247–2256.; Graham R., Mancher M., Miller Wolman D. et al. Clinical practice guidelines we can trust, Institute of Medicine Committee on standards for developing trustworthy clinical practice guidelines. Washington, DC, USA: National Academies Press. 2011.; Guidet B., Martinet O., Boulain T. et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study // Crit. Care. – 2012. ‒ Vol. 16. ‒ Р. 464.; Higgins J. P. T., Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration; 2011; [Updated March 2011]. Available from http://handbook.cochrane.org.; https://en.oxforddictionaries.com/definition/anaesthesiology.; https://www.britannica.com/science/anesthesiology.; Hydroxyethyl-starch solutions for infusion to be suspended – CMDh endorses PRAC recommendation [Internet] (Accessed 25 November 2018). Available from: https://www.ema.europa.eu/news/hydroxyethyl-starchsolutions-infusion-be-suspended-cmdh-endorses-prac-recommendation.; Jamali I. N., Kersten J. R., Pagel P. S. et al. Intracoronary levosimendan enhances contractile function of stunned myocardium // Anesth. Analg. – 1997. – Vol. 85. – P. 23–29.; Jiang L., Jiang S., Zhang M. et al. Albumin versus other fluids for fluid resuscitation in patients with sepsis: a meta-analysis // PLoS One. – 2014. – Vol. 9. ‒ Р. e114666.; Kristensen S. D., Knuuti J., Saraste A. et al. ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA) // Eur. J. Anaesthesiol. – 2014. – Vol. 31, № 10. – P. 517‒573.; Landoni G., Augoustides J. G., Guarracino F. et al. Mortality reduction in cardiac anesthesia and intensive care: results of the first International Consensus Conference // Acta Anaesth. Scand. – 2011. – Vol. 55. – P. 259‒266.; Landoni G., Lomivorotov V. V., Alvaro G. et al. Levosimendan for hemodynamic support after cardiac surgery // N. Engl. J. Med. – 2017. – Vol. 376. – P. 2021‒2031.; Lepran I., Pollesello P., Vajda S. et al. Preconditioning effects of evosimendan in a rabbit cardiac ischemia-reperfusion model // J. Cardiovasc. Pharmacol. – 2006. – Vol. 48. – P. 148–152.; Levijoki J., Pollesello P., Kaheinen P. et al. Improved survival with simendan after experimental myocardial infarction in rats // Eur. J. Pharmacol. – 2001. – Vol. 419. – P. 243–248.; Martin C., Cortegiani A., Gregoretti C. Choice of fluids in critically ill patients // BMC Anesthesiology. ‒ 2018. – Vol. 18. ‒ Р. 200.; Marx G., Schindler A. W., Mosch C. et al. Intravascular volume therapy in adults // Eur. J. Anaesthesiol. – 2016. – Vol. 33. – P. 1–34.; Mehta R. H., Leimberger J. D., van Diepen S. et al. Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery // N. Engl. J. Med. – 2017. – Vol. 376. – P. 2032‒2042.; Messina A., Greco M., Cecconi M. Fluids in shock. Fluid management during shock from physiology to bedside // ICU managment and practice. – 2018. ‒ Vol. 18, № 3. ‒ P. 233‒240.; Moher D., Liberati A., Tetzlaff J. et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement // BMJ. ‒ 2009. – Vol. 339. ‒ Р. b2535.; Murry C. E., Jennings R. B., Reimer K. A. Precondicioning with ischemia: a delay of lethal cell injury in ischemic myocardium // Circulation. ‒ 1986. ‒ Vol. 74. ‒ P. 1124–1136.; Myburgh J. A., Finfer S., Bellomo R. et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care // N. Engl. J. Med. – 2012. – Vol. 367. – P. 1901–1911.; Myburgh J. A., Mythen M. G. Resuscitation Fluids // N. Engl. J. Med. – 2013. – Vol. 369. – P. 1243–1251.; Niven D. J., McCormick T. J, Straus S. E. et al. Reproducibility of clinical research in critical care: a scoping review // BMC Med. – 2018. ‒ Vol. 16, № 26. – Р. 124‒132.; Patel A., Laffan M. A., Waheed U. et al. Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality // BMJ. – 2014. – Vol. 349. ‒ Р. g4561.; Perel P., Roberts I., Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients // Cochrane Database Syst Rev. – 2011. – Vol. 16, № 3. ‒ CD000567.; Perner A., Haase N., Guttormsen A. B. et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis // N. Engl. J. Med. – 2012. ‒ Vol. 367. – P. 124–134.; Scheingraber S., Rehm M., Sehmisch C. et al. Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery // Anesthesiology. – 1999. –Vol. 90. – P. 1265–1270.; Schindler A. W., Marx G. Evidence-based fluid management in the ICU // Curr. Opin. Anaesthesiol. – 2016. – Vol. 29. – P. 158–165.; Shaneyfelt T. M., Centor R. M. Reassessment of clinical practice guidelines: go gently into that good night // JAMA. – 2009. – Vol. 301. – P. 868–869.; Shin C. H., Long D. R., McLean D. et al. Effects of intraoperative fluid management on postoperative outcomes: a hospital registry study // Ann. Surg. – 2018. – Vol. 267. – P. 1084–1092.; Sniderman A. D., Furberg C. D. Why guideline-making requires reform // JAMA. – 2009. – Vol. 301. – P. 429–431.; Thacker J. K. M., Mountford W. K., Ernst F. R. et al. Perioperative fluid utilization variability and association with outcomes: considerations for enhanced recovery efforts in sample US surgical populations // Ann. Surg. – 2016. – Vol. 263. – P. 502–510.; Toller W., Heringlake M., Guarracino F. et al. Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion // Int. J. Cardiology. – 2015. ‒ Vol. 184. – P. 323–336.; Von Heymann C., Sander M., Spies C. D. Protocols, physiology, and trials of hydroxyethyl starch // N. Engl. J. Med. – 2012. – Vol. 367. – P. 1265–1267.; Weber N. C., Precker B., Shlack W. The effect of anesthetics on the myocardium – new insights into protection // Europ. J. Anest. ‒ 2005. ‒ Vol. 22, № 9. ‒ P. 647‒657.; Wiedermann C. J., Eisendle K. Comparison of hydroxyethyl starch regulatory summaries from the Food and Drug Administration and the European medicines agency // J. Pharm. Policy Pract. – 2017. ‒ Vol. 10, № 12. ‒ P. 64‒68.; Woodcock T. E., Woodcock T. M. Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy // Brit. J. Anaesthesia. – 2012. ‒ Vol. 108, № 3. – P. 384–394.; Xu J.-Y., Chen Q.-H., Xie J.-F. et al. Comparison of the effects of albumin and crystalloid on mortality in adult patients with severe sepsis and septic shock: a meta-analysis of randomized clinical trials // Crit. Care. – 2014. – Vol. 18. – P. 702‒712.; Yunos N., Bellomo R., Glassford N. Chlorideliberal vs. chloride-restrictive intravenous fluid administration and acute kidney injury: an extended analysis // Int. Care Med. ‒ 2015. – Vol. 41. – P. 257–264.; Yunos N. M., Bellomo R., Hegarty C. et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults // JAMA. ‒ 2012. ‒ Vol. 308. – P. 1566–1572.; Zangrillo A., Alvaro G., Belletti A. et al. Effect of Levosimendan on renal outcome in cardiac surgery patients with chronic kidney disease and perioperative cardiovascular dysfunction: a substudy of a multicenter randomized trial // J. Cardioth. Vasc. Anesthesia. – 2018. ‒ Vol. 32. – P. 2152‒2159.